{
  "ticker": "EMD",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02959566",
  "id": "02959566",
  "pages": 9,
  "price_sensitive": false,
  "date": "20250618",
  "time": "0944",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250618/pdf/06kvr5gz5mt7w0.pdf",
  "summary": "**Capital Raising Announcement Summary**  \n- **Structure**: Placement with attaching options  \n- **Total Capital Raised**: AUD ~6.5M (166,666,667 shares @ $0.024 + 60,138,889 options exercisable at $0.05)  \n- **Key Dates**: Proposed issue date 25/6/2025. Shareholder approval required by 18/8/2025 for tranche 2.  \n- **Use of Proceeds**: Rollout of treatment programs (including Medibank-funded initiatives) and working capital.  \n- **Broker Fees**: 2% on total raise + 4% on GBA-introduced funds + 2.5M options.  \n- **Placement Capacity**: Utilized 15% (71.3M shares) and 10% (48.9M shares) under ASX Listing Rules 7.1/7.1A.  \n\n**Key Dilution Points**:  \n- New shares issued: **172.9M** (166.7M placement + 6.3M investor relations).  \n- Options issued: **60.1M** (55.6M attaching to placement + 2.5M broker + 2.1M investor relations), exercisable at $0.05 by 18/2/2027.  \n\n*Omitted: Legal boilerplate, director names, non-material fees.*",
  "usage": {
    "prompt_tokens": 3925,
    "completion_tokens": 296,
    "total_tokens": 4221,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-18T00:01:54.505323"
}